Active ingredientTegafurCat. No. P-T033-001CAS 17902-23-7Family · Pharmaceutical analytical standards
Tegafur
An oral prodrug of 5-fluorouracil, which the body converts into the active drug: patented in 1967 and in medical use since 1972, it is used in chemotherapy for cancers such as stomach and colorectal cancer, often in combination. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It was developed in Latvia, then part of the Soviet Union, by the group of chemist Solomon Hillers; from 1972 it was also exported to Japan.
Go to the active ingredient →Active ingredientTegafurCat. No. P-T033-001CAS 17902-23-7
Isotopically labelledTegafur-13C-15N2Cat. No. P-T033-002CAS 1189456-27-6
Isotopically labelledTegafur-d7Cat. No. P-T033-003
ImpurityTegafur Impurity 1Cat. No. P-T033-004
ImpurityTegafur Impurity 2Cat. No. P-T033-005
ImpurityTetrahydrofuran-2-olCat. No. P-T033-006CAS 5371-52-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.